| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 3524 | 2019 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1286 | 2012 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 1213* | 2015 |
| EULAR recommendations for the management of antiphospholipid syndrome in adults MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ... Annals of the rheumatic diseases 78 (10), 1296-1304, 2019 | 1158 | 2019 |
| Comparison of evidence of treatment effects in randomized and nonrandomized studies JPA Ioannidis, AB Haidich, M Pappa, N Pantazis, SI Kokori, ... Jama 286 (7), 821-830, 2001 | 1031 | 2001 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 949 | 2017 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 933 | 2010 |
| Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis P Skendros, A Mitsios, A Chrysanthopoulou, DC Mastellos, S Metallidis, ... The Journal of clinical investigation 130 (11), 6151-6157, 2020 | 764 | 2020 |
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th … G Ruiz-Irastorza, MJ Cuadrado, I Ruiz-Arruza, R Brey, M Crowther, ... Lupus 20 (2), 206-218, 2011 | 638 | 2011 |
| Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial FA Houssiau, D D'Cruz, S Sangle, P Remy, C Vasconcelos, R Petrovic, ... Annals of the rheumatic diseases 69 (12), 2083-2089, 2010 | 597 | 2010 |
| Risk of end‐stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta‐analysis MG Tektonidou, A Dasgupta, MM Ward Arthritis & rheumatology 68 (6), 1432-1441, 2016 | 539 | 2016 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 463 | 2024 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 444 | 2023 |
| Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies MG Tektonidou, K Laskari, DB Panagiotakos, HM Moutsopoulos Arthritis Care & Research 61 (1), 29-36, 2009 | 443 | 2009 |
| 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... Autoimmunity reviews 13 (6), 685-696, 2014 | 381 | 2014 |
| EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome GC Drosos, D Vedder, E Houben, L Boekel, F Atzeni, S Badreh, ... Annals of the rheumatic diseases 81 (6), 768-779, 2022 | 313 | 2022 |
| Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long‐term outcome MG Tektonidou, F Sotsiou, L Nakopoulou, PG Vlachoyiannopoulos, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 311 | 2004 |
| Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution I Moyssakis, MG Tektonidou, VA Vasilliou, M Samarkos, V Votteas, ... The American journal of medicine 120 (7), 636-642, 2007 | 306 | 2007 |
| Carbon dioxide capture for storage in deep geologic formations-results from the CO2 Capture Project: Vol 2-Geologic Storage of Carbon Dioxide with Monitoring and Verification DC Thomas, SM Benson Elsevier, 2015 | 270 | 2015 |
| The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on … MM Abreu, A Danowski, DG Wahl, MC Amigo, M Tektonidou, MS Pacheco, ... Autoimmunity reviews 14 (5), 401-414, 2015 | 263 | 2015 |
